Form4.ai tracks every SEC insider trade in real time. See every APVO insider filing with a free account — no card.
See every APVO insider filing — free account, no card.
Free accountAptevo Therapeutics Inc. (APVO) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 10, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 10, 2026 SEC filing | Harsanyi Zsolt Director | Option exercise | — | — |
| Aug 10, 2026 SEC filing | Lamothe Jeffrey G. President and CEO | Option exercise | — | — |
| Aug 10, 2026 SEC filing | Taylor Daphne SVP, CFO | Option exercise | — | — |
Create a free account to see all 10 APVO filings from the last 90 days. No card needed.
Create free accountWant APVO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.